Natalie Berner

Director/Board Member at BIOINVENT INTERNATIONAL AB

36 year

Health Technology

Consumer Services

Finance

Profile

Natalie Berner is currently an Independent Director at BioInvent International AB since 2022, Managing Director at Redmile Group LLC since 2018, Director at Sensorion SA, Non-Executive Director at Redx Pharma Plc since 2021, and Director at Hansa Biopharma AB starting in 2025.
Formerly, Ms. Berner was a Research Associate at New York University School of Medicine.
Education includes an undergraduate degree from Brown University conferred in 2012.

Natalie Berner active positions

Companies	Position	Start
BIOINVENT INTERNATIONAL AB	Director/Board Member	12/07/2022
REDX PHARMA LTD	Director/Board Member	18/05/2021
SENSORION	Director/Board Member	-
HANSA BIOPHARMA AB	Director/Board Member	02/09/2025
Redmile Group LLC Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team.	Portfolio Manager-Equities	01/08/2018

All active positions of Natalie Berner

Former positions of Natalie Berner

Companies	Position	End
New York University School of Medicine New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Natalie Berner's experience

Training of Natalie Berner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Natalie Berner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BioInvent International AB BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment	Health Technology
Redmile Group LLC Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team.	Finance
Hansa Biopharma AB Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory	Health Technology
Sensorion SA Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders	Health Technology
Redx Pharma Plc Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease	Health Technology
New York University School of Medicine New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services